A well-known pharmaceutical drug with six indications, received multiple safety label updates within one year. The changes to the label impacted the Important Safety Information, which in turn required updating of each indication’s marketing materials (print and digital). Numerous and digital assets (HCP and Patient), as well as scripts and materials needed for a Patient Support program required updating, or they risked pulled from market use. The marketing assets needed to be audited, revised, and approved within a 90-day period.
A CMK Project Manager requested system reports to identify the brand’s marketing materials. Working with brand stakeholders, the materials were then audited (keep/remove/revise) and prioritized for market use. The CMK Project Manager worked closely with external agencies and internal reviewers to ensure the key marketing materials were reviewed and approved for use within the designated period.